HealthManagement, Volume 7 - Issue 1, 2012 HIT

First Databank (FDB), provider of drug knowledge bases and clinical decision support, has announced the continuation of the successful partnership with Helix Health. The contract provides Helix Health with FDB’s clinical databases for the next three years. Helix Health is continuing to use FDB’s information within their product suite in the Republic of Ireland and UK, targeted towards hospital pharmacies and other healthcare sites. FDB’s drug knowledge forms a core part of Helix Health’s QicScript product range which is tailored to the community pharmacies both in the UK and Republic of Ireland.

Crevan O’Malley, group commercial manager at Helix Health explains why they decided to extend the contract; “We have dealt with First Databank for over 10 years, and they have provided us with an unfailing, high-calibre service over this period. Our customers rely on our products and services and First Databank’s clinical databases form a core component to our offer. First Databank is a trusted partner of ours.”

FDB’s drug knowledge is featured within the QicScript product range delivering information on more than 10,000 pharmaceutical products to Helix Health’s customers. Helix Health’s QicScript.net product is a dispensary management system that helps pharmacists to deliver efficient, safe and cost-effective patient services. With advanced clinical support, QicScript. net allows the user to record detailed patient notes. First Databank’s drug knowledge provides users with immediate access to comprehensive electronic drug information at the point-of-care which has a number of documented benefits including reduction of medication errors; reduction of costs associated with medication related harm, improved patient care, and improved efficiencies in workflow.

The partnership between FDB and Helix Health will ensure the continued development of innovative solutions and delivery of first-class services to customers in the Republic of Ireland and the UK.

«« Rolling out New Medical Products in the Market: Simulation Helps Reduce Major Risks for Patients


8th WHCC - Europe »»